Technical Analysis for ACRS - Aclaris Therapeutics, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| See historical ACRS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Outside Day | Range Expansion | 6.80% | |
| Down 3 Days in a Row | Weakness | 6.80% | |
| NR7 | Range Contraction | 1.85% | |
| Wide Bands | Range Expansion | 1.85% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | -0.90% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -0.90% | |
| Inside Day | Range Contraction | -0.90% | |
| Wide Bands | Range Expansion | -0.90% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/08/2019
- Sector: Healthcare
- Industry: Biotechnology
Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Medicine Chemistry Pharmaceutical Chemical Substances Topical Medication Common Warts Wart
Medicine Chemistry Pharmaceutical Chemical Substances Topical Medication Common Warts Wart
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more ACRS news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 15.98 |
| 52 Week Low | 0.74 |
| Average Volume | 1,015,659 |
| 200-Day Moving Average | 4.9804 |
| 50-Day Moving Average | 1.3523 |
| 20-Day Moving Average | 1.0108 |
| 10-Day Moving Average | 1.0281 |
| Average True Range | 0.1197 |
| ADX | 33.57 |
| +DI | 14.842 |
| -DI | 19.189 |
| Chandelier Exit (Long, 3 ATRs ) | 0.8209 |
| Chandelier Exit (Short, 3 ATRs ) | 1.0991 |
| Upper Bollinger Band | 1.1396 |
| Lower Bollinger Band | 0.882 |
| Percent B (%b) | 0.85 |
| BandWidth | 25.484765 |
| MACD Line | -0.0883 |
| MACD Signal Line | -0.1481 |
| MACD Histogram | 0.0597 |
| Fundamentals | Value |
|---|---|
| Market Cap | 29.41 Million |
| Num Shares | 26.7 Million |
| EPS | -2.03 |
| Price-to-Earnings (P/E) Ratio | -0.54 |
| Price-to-Sales | 0.00 |
| Price-to-Book | 3.83 |
| PEG Ratio | -0.13 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.24 | ||||
| Resistance 3 (R3) | 1.23 | 1.17 | 1.21 | ||
| Resistance 2 (R2) | 1.17 | 1.14 | 1.18 | 1.20 | |
| Resistance 1 (R1) | 1.14 | 1.12 | 1.16 | 1.15 | 1.20 |
| Pivot Point | 1.08 | 1.08 | 1.09 | 1.09 | 1.08 |
| Support 1 (S1) | 1.05 | 1.05 | 1.07 | 1.06 | 1.00 |
| Support 2 (S2) | 0.99 | 1.03 | 1.00 | 1.00 | |
| Support 3 (S3) | 0.96 | 0.99 | 0.99 | ||
| Support 4 (S4) | 0.97 |
